Sonova Holding (OTCMKTS:SONVY) Given Average Rating of “Hold” by Analysts

Shares of Sonova Holding (OTCMKTS:SONVY) have been given an average recommendation of “Hold” by the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, two have given a buy recommendation and one has issued a strong buy recommendation on the company.

SONVY has been the subject of a number of recent research reports. Citigroup reissued a “sell” rating on shares of Sonova in a research report on Friday, July 24th. UBS Group raised Sonova from a “hold” rating to a “buy” rating in a research report on Wednesday, July 22nd. Finally, Morgan Stanley upgraded Sonova from an “underweight” rating to an “equal weight” rating in a research note on Tuesday, June 23rd.

Sonova Trading Up 0.2%

Sonova stock opened at $59.11 on Monday. Sonova has a 12 month low of $42.26 and a 12 month high of $61.09. The company has a current ratio of 1.75, a quick ratio of 1.43 and a debt-to-equity ratio of 0.51. The business’s 50 day simple moving average is $51.91 and its 200 day simple moving average is $49.93.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.